PharmaCyte Biotech (PMCB) Stock Chart & Stock Price History $1.24 0.00 (0.00%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PharmaCyte Biotech Stock Price Performance 5 Day Performance+1.64%1 Month Performance-6.06%3 Month Performance-22.74%6 Month Performance-33.69%Year-To-Date Performance-21.02%1 Year Performance-41.51% Receive PMCB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address PMCB Stock Chart for Wednesday, April, 30, 2025 PMCB Chart by TradingView PharmaCyte Biotech Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/29/2025$1.29$1.24-3.88%$1.30$1.2111,686 shs$8.51 million04/28/2025$1.22$1.29+5.74%$1.27$1.2011,283 shs$8.86 million04/25/2025$1.21$1.22+0.83%$1.24$1.175,043 shs$8.37 million04/24/2025$1.19$1.21+1.68%$1.32$1.1525,515 shs$8.31 million04/23/2025$1.15$1.19+3.93%$1.27$1.155,354 shs$8.17 million04/22/2025$1.13$1.15+1.33%$1.18$1.1117,701 shs$7.86 million04/21/2025$1.19$1.13-4.64%$1.19$1.123,212 shs$7.76 million04/18/2025$1.19$1.19$1.20$1.0313,357 shs$8.13 million04/17/2025$1.15$1.19+3.04%$1.20$1.0313,357 shs$8.13 million04/16/2025$1.27$1.15-9.45%$1.24$1.1322,963 shs$7.89 million Get the Latest News and Ratings for PMCB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter. 04/15/2025$1.20$1.27+5.83%$1.27$1.156,247 shs$8.72 million04/14/2025$1.13$1.20+6.67%$1.20$1.183,535 shs$8.24 million04/11/2025$1.14$1.13-1.32%$1.23$1.1614,608 shs$7.72 million04/10/2025$1.21$1.14-5.39%$1.28$1.1025,900 shs$7.83 million04/09/2025$1.19$1.21+1.69%$1.21$1.0538,182 shs$8.27 million04/09/2025$1.19$1.21+1.69%$1.21$1.0538,182 shs$8.27 million04/08/2025$1.14$1.19+3.95%$1.23$1.149,563 shs$8.13 million04/08/2025$1.14$1.19+3.95%$1.23$1.149,563 shs$8.13 million04/07/2025$1.24$1.14-8.06%$1.24$1.1220,122 shs$7.83 million04/04/2025$1.24$1.24$1.33$1.2411,482 shs$8.51 million04/03/2025$1.30$1.24-4.62%$1.38$1.2415,283 shs$8.51 million04/02/2025$1.29$1.30+0.78%$1.40$1.2513,272 shs$8.92 million04/01/2025$1.25$1.29+3.20%$1.32$1.229,792 shs$8.86 million03/31/2025$1.32$1.25-5.30%$1.46$1.2318,546 shs$8.58 million Related Companies RNXT Stock Chart DYAI Stock Chart AKTX Stock Chart AADI Stock Chart NRXP Stock Chart BRNS Stock Chart OKUR Stock Chart ALVR Stock Chart FGEN Stock Chart LVTX Stock Chart Receive PMCB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PMCB) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmaCyte Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmaCyte Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.